Class 3 recall- Fingolimod Glenmark 0.5 mg Hard Capsules

CLASS 3 RECALL

PLEASE READ AND CONFIRM THAT YOU HAVE RECEIVED THIS.

We have received a Class 3 Recall from Glenmark Pharmaceuticals Europe Limited on FINGOLIMOD CAP 0.5MG

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-glenmark-pharmaceuticals-europe-limited-fingolimod-glenmark-0-dot-5-mg-hard-capsules-el-26-a-slash-02?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=53be9484-a57c-41df-9fe0-10338d61497b&utm_content=immediately

MHRA ref: DMRC-38142990

Reason: Glenmark Pharmaceuticals Europe Limited is recalling the above batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule dissolution.

Please can you ensure that your stores quarantine the product listed below.

Further Information

For all medical information enquiries and information on this product, medical_information@glenmarkpharma.com or telephone 0044 8004 580 383

For stock control enquiries please email orders.uk@glenmarkpharma.com

Please return all affected stock to your original supplier for credit. As Alliance Healthcare has not supplied the affected batch, we will not be accepting returns.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.